[ Price : $8.95]
Janssen Pharmaceutical files a BLA for amivantamab for treating certain patients with metastatic non-small cell lung cancer.[ Price : $8.95]
FDA alerts health care professionals about the risk of inadvertent intrathecal administration with tranexamic acid injection, whic...[ Price : $8.95]
TG Therapeutics begins a rolling BLA submission for ublituximab in combination with umbralisib as a treatment for patients with ch...[ Price : $8.95]
FDA publishes the latest update to the SARS-CoV-2 reference panel of standardized samples.[ Price : $8.95]
FDA approves a Vanda Pharmaceuticals NDA for Hetlioz (tasimelteon) capsule and liquid formulations for treating adults and childre...[ Price : $8.95]
Federal Register notice: FDA announces a 12/17 advisory committee meeting to discuss an emergency use authorization request by Mod...[ Price : $8.95]
Federal Register notice: FDA posts five information collections that have been approved by OMB.[ Price : $8.95]
FDA approves a broader indication for Blueprint Medicines Gavreto to treat some thyroid cancers.